جست‌وجوی استاد و پژوهشگر

John Fifeمشاهده پروفایل

استاد پژوهشی

• STEM Identity Development
• Educational Resilience
• STEM Equity
• +۱ مورد دیگر

Dr. John Fife is an Associate Research Professor of STEM Education in the Department of Foundations of Education at Virginia Commonwealth University. His research focuses on building STEM identity and resilience among underserved youth, examining psychosocial implications of STEM inequity, and developing culturally relevant STEM ecosystems. He holds a Ph.D. in Counseling Psychology from VCU and completed postdoctoral training at the Medical College of Virginia. Education: Ph.D. in Counseling Psychology, Virginia Commonwealth University M.S. in Counseling Psychology, Virginia Commonwealth University B.S. in Psychology, University of Massachusetts at Boston B.S. in African American Studies, University of Massachusetts at Boston Fife has secured significant funding including NSF grants for Building Capacity in STEM Education Research ($346,000) and STEM learning ecosystems ($295,000). His publications explore academic resilience, equity in STEM, and culturally responsive interventions. Major Grants: Principal Investigator: NSF BCSER grant #2126016 ($346,000, 2021-2023) Principal Investigator: NSF MCA grant #2219175 ($295,000, 2022-2025) Principal Investigator: NSF HBCU-UP grant #1238757 ($349,000, 2010-2013) Honors: American Association of Blacks in Higher Education Leadership Fellow (2022) VSU/Massey Cancer Center Faculty Fellow (2021-2024) Harvard Management Development Program (2018)

Kajal Gokalمشاهده پروفایل

عضو هیئت علمی

• Behavioral Medicine
• Cancer Prevention
• Behavior Change
• +۳ مورد دیگر

Kajal Gokal is a Senior Research Fellow at Loughborough University, supported by an NIHR Advanced Fellowship. Her research focuses on behavioral medicine, particularly behavioral interventions for cancer prevention and management. She leads the Prevention and Treatment of Chronic Illness theme within the Centre for Lifestyle Medicine and Behaviour. Kajal holds a PhD in Psychology from Loughborough University and an undergraduate degree in Psychology from Aston University. Her professional journey includes roles as a Research Associate at Coventry University and Senior Research Associate on the NIHR-funded Snacktivity program (2019–2020). She has collaborated on projects funded by NIHR, MRC, and CRUK, developing digital health interventions and evaluating their impact. Key areas of expertise include physical activity promotion, behavior change techniques, and health professional-patient communication. Key research interests involve using small behavior changes (e.g., Snacktivity™) to address sedentary lifestyles and cancer risks, alongside co-designing interventions with communities. Her work integrates qualitative and quantitative methods, including randomized controlled trials and feasibility studies. Scientific achievements include the NIHR Advanced Fellowship (2024) and contributions to systematic reviews on physical activity outcomes in cancer patients and weight management strategies. Kajal’s interventions often target underserved populations, such as low-resourced mothers and cancer survivors, emphasizing social cohesion and accessibility.

Steven Hettsمشاهده پروفایل

دانشیار

• Interventional Neuroradiology
• Endovascular Therapy
• Cerebrovascular Disease
• +۴ مورد دیگر

Steven Hetts, MD, is an Associate Professor of Radiology in Residence at the University of California, San Francisco (UCSF), and Chief of Neuroradiology at San Francisco General Hospital. He established the Interventional Neuroradiology service, specializing in cutting-edge endovascular therapies for cerebrovascular and spinal vascular diseases. His academic roles include Co-Director of the Interventional Radiology Laboratory at China Basin, focusing on translational research bridging engineering and clinical applications. Education: AB in Biology, Harvard College (1996) MD, Harvard Medical School (2000) Residency in Diagnostic Radiology, UCSF (2005) Fellowships in Diagnostic Neuroradiology and Interventional Neuroradiology, UCSF (2006, 2008) Research Interests: Dr. Hetts' work centers on endovascular therapies for cerebrovascular and spinal diseases, neurooncology, and advancing minimally invasive techniques. Key projects include Magnetic Catheter Navigation and the ChemoFilter system to reduce chemotherapy toxicity. His clinical research emphasizes translating basic science into clinical solutions. Grants & Funding: NIH R42CA265316 (2021-2022): Endovascular ChemoFilter NIH R01EB012031 (2011-2022): MRI Tools for Endovascular Interventions NIH R01CA194533 (2015-2021): Endovascular Chemofiltration Awards: Margulis Society Radiology Resident Research Award (2003) American Society of Neuroradiology Scholar Award (2012) Nominated for QB3 Startup of the Year (2015) Labs & Teams: Co-Director of the Interventional Radiology Laboratory at China Basin, collaborating on projects like the ChemoFilter system and MRI optimization for endovascular procedures.

John J. Lucidoمشاهده پروفایل

عضو هیئت علمی

• Treatment planning for radiation therapy
• Special procedures in radiation therapy
• Quality assurance in radiation therapy
• +۵ مورد دیگر

John J. Lucido, III, Ph.D., is a Medical Physicist at the Mayo Clinic in Rochester, Minnesota, specializing in Radiation Oncology . He is affiliated with the Mayo Clinic College of Medicine and Science and actively involved in clinical research, education, and global medical physics initiatives. Education: Ph.D. in Medical Physics (2013) - University of British Columbia M.S. in Mathematical Physics (2008) - Rutgers University B.S.E. in Engineering Physics - Electrical Engineering (2008) - University of Michigan Dr. Lucido's research focuses on advanced radiation therapy techniques , including: Automated treatment planning systems Dosimetric characterization of novel radiation devices Machine learning applications in organ-at-risk segmentation Clinical decision tools for spine stereotactic body radiation therapy (SBRT) Quality assurance protocols for radiation delivery His publications highlight the integration of Monte Carlo simulations , deep learning , and radiobiological modeling to optimize radiation therapy for complex cases such as pregnant patients, ultracentral lung cancers, and skin electron beam therapy. Scientific awards and honors include: Teacher of the Year - Radiation Physics (Mayo Clinic, 2022) International Graduate Student Fellowship (University of British Columbia, 2009) Graduate Aid in Areas of National Need Fellowship (Rutgers University, 2005) Certified Therapeutic Medical Physicist (American Board of Radiology, 2016) Dr. Lucido actively contributes to professional societies as a Voting Member of the Society of Directors of Academic Medical Physics Programs (SDAMPP) , Chair of the Eclipse Scripting and Automation Group , and International Consultant for C/CAN - Kumasi City Radiotherapy Project . He also serves on multiple Mayo Clinic committees related to education and quality assurance. His work emphasizes global radiation therapy standardization and educational infrastructure development , particularly in underserved regions like Ghana. Recent projects include automated testing platforms for treatment planning scripts and customizable radiation shields for skin therapy.

Anders Erik Astrup Dahmمشاهده پروفایل

دانشیار

• Thrombosis Research
• Hemostasis
• Cancer Biology
• +۳ مورد دیگر

Anders Erik Astrup Dahm is an Associate Professor at Akershus University Hospital, affiliated with the Department of Internal Medicine and Laboratory Sciences. His research focuses on thrombosis, hemostasis, and cancer-related coagulation disorders with a strong emphasis on clinical translation. He leads studies investigating anticoagulant therapies (e.g., apixaban, rivaroxaban), the impact of hormones on coagulation, and exercise-based rehabilitation for pulmonary embolism survivors. Dahm has contributed to understanding mechanisms behind cancer-associated thrombosis and improving diagnostic protocols for venous thromboembolism. His work frequently involves clinical trials and observational studies, often in collaboration with international teams. Affiliations: Akershus University Hospital, CEHRA Center for Hematological Research Research interests span thrombosis prevention in oncology patients, coagulation factor regulation, and circadian rhythm effects on hemostatic systems. Recent studies explore drug interactions with novel anticoagulants and exercise interventions for post-embolism dyspnea. Dahm's work bridges basic science and clinical practice, addressing challenges in managing complex hematological conditions. Key articles highlight advancements in apixaban dosing strategies for cancer patients, ruxolitinib efficacy in myeloproliferative disorders, and diagnostic accuracy of imaging techniques in bone fractures associated with multiple myeloma. Advising/grants: While no formal student advisees are listed, Dahm leads numerous grant-funded studies on thrombosis mechanisms and clinical interventions. His research is supported by institutions including the Norwegian Medical Association and UiO collaborations. Labs/teams: Primary affiliation with CEHRA (Center for Hematological Research) at Akershus University Hospital, collaborating on translational hematology projects.

• Pharmaceutical Policy Analysis
• Pharmacoepidemiology
• Pharmacovigilance
• +۴ مورد دیگر

Prof. Aukje Mantel-Teeuwisse is a Professor of Pharmacy and Global Health at Utrecht University, leading the Undergraduate School of Science since 2023. She holds a PharmD from Utrecht University (1998), followed by a PhD in Pharmacoepidemiology (2004). Her career includes roles as a community pharmacist, academic researcher, and part-time liaison at the Dutch Medicines Evaluation Board (2005–2010). Currently, she also serves as Scientific Director of the WHO Collaborating Centre for Pharmaceutical Policy and Regulation, focusing on global health policy, drug regulation, and pharmaceutical policy analysis. Her research emphasizes global health equity, drug regulatory science, and medicine use variation. Over 200 peer-reviewed articles highlight her contributions to HTA methodologies, oncology drug economics, and access to medicines in low-resource settings. Educationally, she oversees Pharmacy and Drug Innovation programs, advocating for digital transformation in pharmaceutical education. Leadership roles include directing Utrecht’s School of Pharmacy (2014–2023) and contributing to international committees on pharmaceutical policy and healthcare access. Key initiatives include addressing medicine shortages, improving access to childhood cancer treatments, and evaluating policies regulating pharmaceutical supply chains. Her work bridges academia, policy, and global health, with a focus on aligning regulatory, HTA, and clinical guideline practices to enhance healthcare outcomes.

Menggang Yuمشاهده پروفایل

استاد

• Causal Inference
• Observational Studies
• Risk Prediction
• +۷ مورد دیگر

Dr. Menggang Yu is a Professor of Biostatistics at the University of Michigan School of Public Health. He holds academic leadership roles, including former Director of the Biostatistics Core at UW Carbone Cancer Center and Associate Director of the Center for Health Disparities Research. His expertise spans causal inference, clinical biostatistics, and precision health, with a focus on cancer and chronic disease research. Education: PhD in Biostatistics (University of Michigan, 2004), MS in Applied Statistics (Bowling Green State University, 1999), BS in Computational Mathematics (Fudan University, 1996). Research interests emphasize causal inference, risk prediction, and treatment selection, particularly in clinical trials and observational studies. His work addresses methodological challenges in healthcare, including optimal surveillance strategies and subgroup analysis. Key awards include the Distinguished Student Paper Award (ENAR 2023) and ASA Biometrics Section Travel Awards (2017, 2018). He collaborates widely, contributing to high-impact journals like Biometrics , Journal of the American Statistical Association , and Cancer Cell . Grants and lab involvement include leadership roles in cores for cancer research and health disparities. Courses taught include survival analysis, causal inference, and clinical trial biostatistics.

• Biostatistics
• Epidemiology
• Health Services Research
• +۱۲ مورد دیگر

Dr. Lin Liu is an Associate Adjunct Professor in the Department of Family Medicine and Public Health at the Herbert Wertheim School of Public Health & Human Longevity Science, UC San Diego. Her research focuses on biostatistical methodologies, including dose-response analysis, longitudinal HIV data modeling, and colorectal cancer prognostic modeling. She collaborates on studies addressing cancer, cardiovascular disease, hepatitis C, chronic pain, HIV/AIDS, and telemedicine. Dr. Liu’s work spans epidemiology, health services research, and clinical trial design. Her research interests include statistical methods for detecting minimum effective doses in toxicity studies, HIV viral load analysis, and predictive models for cancer recurrence. She has contributed to studies on opioid use, tuberculosis treatment adherence, and yoga interventions for chronic pain. Dr. Liu’s publications reflect her expertise in applying statistical techniques to public health challenges, such as improving cancer screening strategies and evaluating telehealth outcomes for mental health conditions like PTSD. Notable contributions include developing prognostic models for colorectal neoplasia recurrence and investigating the efficacy of videoconferencing psychotherapy. Her interdisciplinary collaborations span infectious disease epidemiology, psychiatric disorders, and biomedical informatics, emphasizing patient-centered care and electronic health record optimization.

• Public Health
• Health Justice
• Bio-cultural Ethics
• +۴ مورد دیگر

B S L Hurst is a Health Sciences Clinical Professor at the Herbert Wertheim School of Public Health & Human Longevity Science, University of California San Diego. Her expertise lies in participatory frameworks prioritizing health equity and justice in public health research, with a focus on marginalized communities including Indigenous populations and ethnic minorities. Dr. Hurst holds a Ph.D. in Biological Anthropology from the University of Tennessee, Knoxville, and completed postdoctoral training in Cultural Psychiatry at The Scripps Research Institute. Her research emphasizes community-driven approaches, bio-cultural ethics, and bridging academic research with practical applications to address socio-cultural health disparities. Key areas include Indigenous health, qualitative methods, and global health justice. She teaches in the Master of Public Health (MPH) and Joint Doctoral Program in Public Health (JDP). Dr. Hurst has contributed to projects with communities such as American Indian, Australian Aborigine, and Somali-American refugees. Her work spans topics like tobacco control, wearable technology, yoga therapy for veterans, and culturally competent mental health services. She collaborates with institutions like UCSF and The Scripps Research Institute, contributing to over two decades of impactful research.

Marijke Mellesمشاهده پروفایل

پژوهشگر

• Digital Health
• Human-Centered Design
• Healthcare Design
• +۳ مورد دیگر

Marijke Melles is a Researcher in the Department of Industrial Design Engineering at Delft University of Technology. Her work focuses on Human-Centered Design and Human Factors, particularly in healthcare contexts. She leads the Value@WORK research project, exploring value-driven care for labor and health. Her research emphasizes digital health design, patient experience frameworks, and participatory design approaches. Key areas include reducing hospital visits through digital interventions, improving communication in medical screenings, and optimizing work-focused healthcare for chronic disease patients. She teaches courses like Research for Design and Capita Selecta Medisign , bridging academic research and practical healthcare applications. Her interdisciplinary contributions span healthcare systems resilience, pandemic preparedness in transport hubs, and collaborative teamwork in clinical settings. She actively participates in professional organizations like Human Factors NL. Her publications highlight innovations in telemedicine, patient journey mapping, and shared decision-making methodologies in oncology.

Martyn Standageمشاهده پروفایل

استاد

• Health Psychology
• Exercise Science
• Behavioral Science
• +۴ مورد دیگر

Martyn Standage is a Professor of Psychology, Health, and Applied Science at the University of Bath's Department for Health. He directs the Centre for Motivation and Behaviour Change and serves as the REF Lead for Unit of Assessment 24. With a PhD from the University of Birmingham (2003), his research focuses on motivational determinants of health behaviors, particularly in exercise, sport, education, and organizational settings. He has authored over 200 publications, securing £8.5M in grants from bodies like the MRC and ESRC. Standage contributes to national/international initiatives, including the UK Physical Activity Guidelines and Active Healthy Kids England's national report card. His work aligns with UN Sustainable Development Goals, emphasizing health and well-being. Education : PhD in Psychology, University of Birmingham (2003). Research Interests : Self-determination theory applications, physical activity interventions, sedentary behavior, and interdisciplinary health research. Recent projects include global surveillance of childhood movement behaviors and behavioral interventions for chronic disease management. Grants & Impact : Over £8.5M in funding; contributed to 4* REF Impact Case Studies (2014, 2021). Editor-in-Chief (2016-2024) of the Journal of Sport & Exercise Psychology; member of multiple expert panels, including Public Health England's 'Moving Medicine' initiative. Labs & Teams : Leads the Centre for Motivation and Behaviour Change, fostering interdisciplinary research on behavior change and public health.

• Intellectual Disability Healthcare
• Public Health
• Epidemiology
• +۳ مورد دیگر

Dr. Laura Ward is a Research Associate at the University of Glasgow's School of Health & Wellbeing. Her work focuses on health disparities among individuals with intellectual disabilities, including oral health, medication safety, and mortality analysis through record linkage studies. She employs functional near-infrared spectroscopy (fNIRS) in neurology research to examine visual cortex function in conditions like diabetes and glaucoma. Her interdisciplinary approach bridges clinical epidemiology with neuroimaging techniques. Research Interests: Health outcomes in intellectual disability populations Pharmacological safety and polypharmacy risks Neuroimaging of visual processing disorders Epidemiological studies of chronic disease disparities Publications Trends: Over 27 peer-reviewed articles and conference presentations since 2013. Recent focus on pandemic impacts (2025), cancer epidemiology (2024), anticholinergic burden analysis (2022-2021), and dental health disparities (2020). Neuroimaging work (2015-2018) explores aging and diabetes effects on visual systems. Grants & Advising: Collaborates with interdisciplinary teams on large-scale cohort studies. No specific grants mentioned, but active in record linkage methodology development. Labs/Teams: Engaged with Glasgow's neuroimaging research groups and intellectual disability healthcare initiatives.

• Biostatistics
• Clinical Trials
• Public Health
• +۳ مورد دیگر

Wendy Jean Mack, PhD, is a Professor of Biostatistics in the Department of Preventive Medicine at the Keck School of Medicine of the University of Southern California (USC). She co-directs the Division of Biostatistics graduate programs and leads Biostatistics Resources at the Southern California Clinical and Translational Science Institute (SC CTSI). With over 20 years of experience, her expertise spans the design, conduct, and analysis of clinical trials and observational studies, particularly in the NIH-funded realm. She directs biostatistical activities for the USC Alzheimer’s Disease Research Center and other research programs. Mack received her doctorate from USC and has contributed to numerous NIH study sections, including the NHLBI Clinical Trials Review panel. Her research focuses on biostatistical methodologies, neurodegenerative diseases, cardiovascular health, and public health interventions. Collaborative projects include studies on Alzheimer’s pathology, iron metabolism, lipid peroxidation, and clinical trial innovations. Her work bridges statistical rigor with translational science, addressing critical questions in aging, chronic disease, and healthcare equity. Notably, recent articles highlight her contributions to understanding SARS-CoV-2 in cord blood, hormone therapy effects, and culturally adapted parenting interventions for Filipino families. Education: PhD in Biostatistics from the University of Southern California Research Interests: Advanced biostatistical methods for clinical trials Neurodegenerative diseases (Alzheimer’s, Parkinson’s) Cardiovascular epidemiology and atherosclerosis progression Impact of hormones on postmenopausal health Public health interventions targeting underserved populations Grants & Funding: Extensive NIH funding for studies on biostatistical coordination, clinical trial design, and translational research in aging and chronic disease. Labs/Teams: Leads biostatistics teams at SC CTSI and the Alzheimer’s Disease Research Center, collaborating with interdisciplinary groups to advance methodological and clinical goals.

• Oocyte and Embryo Development
• Reproductive Endocrinology
• Cancer Treatment Effects on Fertility
• +۴ مورد دیگر

Lynda Kay McGinnis, PhD is an Assistant Professor of Research in Obstetrics & Gynecology at the University of Southern California. Her research focuses on oocyte and embryo health, specifically investigating how microenvironmental factors and chemotherapy treatments impact fertility outcomes. She collaborates closely with clinicians at USC Fertility Clinic and the Division of Reproductive Endocrinology and Infertility to develop clinical applications like the KSOMaa culture media, now widely used globally. Current studies include long-term effects of cancer treatments (e.g., Gleevec/Tamoxifen) on ovarian function and the role of exosomes in oocyte signaling. Her work bridges basic science and clinical practice, addressing infertility mechanisms through projects like exosome-mediated cell communication and biomarker development for reproductive health. She explores how extracellular vesicles influence oocyte quality and embryo viability, with implications for improving IVF success rates and fertility preservation strategies for cancer patients. Research areas span reproductive endocrinology, oncofertility, and developmental biology. Key projects include longitudinal studies on antimüllerian hormone correlations with puberty milestones, and predictive models for live birth rates post-embryo transfer. Her lab also investigates molecular mechanisms underlying fertilization signaling pathways and age-related reproductive decline.

• Neuroblastoma Research
• Pediatric Oncology
• Clinical Trials in Oncology
• +۳ مورد دیگر

Judith G. Villablanca, MD, is a Clinical Professor (Part-Time) in the Department of Pediatrics at the Keck School of Medicine of USC. She is affiliated with The Saban Research Institute and Children’s Hospital Los Angeles (CHLA). Her research focuses on pediatric oncology, particularly neuroblastoma, with an emphasis on clinical trials, therapeutic strategies, and biomarker discovery. Dr. Villablanca has contributed to phase I/II studies evaluating novel agents like lorlatinib, vorinostat, and targeted radiotherapies. Her work addresses therapeutic efficacy, drug safety, and prognostic markers for high-risk neuroblastoma. She is actively involved in the New Approaches to Neuroblastoma Therapy (NANT) consortium and the Children’s Oncology Group (COG), leading efforts in optimizing treatment protocols and response criteria. Key contributions include biomarker-driven studies, safety assessments of MIBG therapy, and evaluating drug combinations such as MIBG with chemotherapy or vorinostat. Her research bridges clinical trials with molecular insights, aiming to improve outcomes for children with refractory or relapsed cancers. Education & Affiliations: While specific educational details are not provided, her roles suggest expertise in pediatric hematology/oncology. She collaborates with leading institutions like CHLA and USC. Research Trends: Her articles emphasize translational research in neuroblastoma, including genomic biomarkers (e.g., gene expression profiling), drug toxicity monitoring (e.g., premature growth plate arrest), and radiotherapy optimization. Recent work highlights lorlatinib’s potential in ALK-driven tumors and revised response criteria for clinical trials. Grants & Awards: Not explicitly listed in the provided text. Labs/Teams: Active in The Saban Research Institute and NANT/COG consortia.